Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wesolowski

Showing results (811-820 of 945) with videos related to

Pageof 95
Sort By:
Frontiers in Immunology|October 29, 2021
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With MelanomaSteven H Sun, Brooke Benner, Himanshu Savardekar, et al.
Breast Cancer Research : BCR|July 2, 2025
Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2- advanced or metastatic breast cancer: phase 1/2 study resultsErika P Hamilton, Manish R Patel, Virginia F Borges, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
Quantifying the role of importation on sustained malaria transmission in a low-to-moderate burden region of Southwest UgandaAdrienne Epstein, Okiria Aramanzan, Isaiah Nabende, et al.
The Journal of Infectious Diseases|January 6, 2026
Quantifying the role of importation on sustained malaria transmission in a low-to-moderate burden region of Southwest UgandaAdrienne Epstein, Okiria Aramanzan, Isaiah Nabende, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor Positive, HER2 Negative Advanced Breast CancerRobert Wesolowski, Hope S Rugo, Jennifer M Specht, et al.
Journal of Affective Disorders|September 8, 2023
Inflamed but not impulsive: Acute inflammatory cytokine response does not impact prepotent response inhibitionAnnelise A Madison, Rebecca Andridge, Megan E Renna, et al.
Nature Communications|August 29, 2023
Effects of public-health measures for zeroing out different SARS-CoV-2 variantsYong Ge, Xilin Wu, Wenbin Zhang, et al.
World Journal of Surgical Oncology|January 16, 2020
Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective studyEvan Morgan, Anupama Suresh, Akaansha Ganju, et al.
Investigational New Drugs|January 19, 2020
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Mohamed Badawi, Ewa Mrozek, et al.
Plos One|April 11, 2014
Long-term resilience of late holocene coastal subsistence system in Southeastern South americaAndré Carlo Colonese, Matthew Collins, Alexandre Lucquin, et al.
Pageof 95

Showing results (811-820 of 945) with videos related to

Sort By:
Pageof 95
Frontiers in Immunology|October 29, 2021
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With MelanomaSteven H Sun, Brooke Benner, Himanshu Savardekar, et al.
Breast Cancer Research : BCR|July 2, 2025
Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2- advanced or metastatic breast cancer: phase 1/2 study resultsErika P Hamilton, Manish R Patel, Virginia F Borges, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
Quantifying the role of importation on sustained malaria transmission in a low-to-moderate burden region of Southwest UgandaAdrienne Epstein, Okiria Aramanzan, Isaiah Nabende, et al.
The Journal of Infectious Diseases|January 6, 2026
Quantifying the role of importation on sustained malaria transmission in a low-to-moderate burden region of Southwest UgandaAdrienne Epstein, Okiria Aramanzan, Isaiah Nabende, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor Positive, HER2 Negative Advanced Breast CancerRobert Wesolowski, Hope S Rugo, Jennifer M Specht, et al.
Journal of Affective Disorders|September 8, 2023
Inflamed but not impulsive: Acute inflammatory cytokine response does not impact prepotent response inhibitionAnnelise A Madison, Rebecca Andridge, Megan E Renna, et al.
Nature Communications|August 29, 2023
Effects of public-health measures for zeroing out different SARS-CoV-2 variantsYong Ge, Xilin Wu, Wenbin Zhang, et al.
World Journal of Surgical Oncology|January 16, 2020
Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective studyEvan Morgan, Anupama Suresh, Akaansha Ganju, et al.
Investigational New Drugs|January 19, 2020
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Mohamed Badawi, Ewa Mrozek, et al.
Plos One|April 11, 2014
Long-term resilience of late holocene coastal subsistence system in Southeastern South americaAndré Carlo Colonese, Matthew Collins, Alexandre Lucquin, et al.
Pageof 95